Financials Lonza Group AG

Equities

LONN

CH0013841017

Biotechnology & Medical Research

Market Closed - Swiss Exchange 11:31:28 2024-05-28 am EDT 5-day change 1st Jan Change
495.2 CHF -3.43% Intraday chart for Lonza Group AG -6.42% +40.01%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 26,224 42,255 56,574 33,615 26,273 35,712 - -
Enterprise Value (EV) 1 29,185 45,068 55,616 33,429 27,195 38,345 39,031 38,993
P/E ratio 40.8 x 48.9 x 19.3 x 27.7 x 39.8 x 40.4 x 32.2 x 26.6 x
Yield 0.78% 0.53% 0.39% 0.66% 1.13% 0.91% 1.07% 1.22%
Capitalization / Revenue 4.43 x 6.83 x 10.5 x 5.4 x 3.91 x 5.36 x 4.65 x 4.16 x
EV / Revenue 4.93 x 7.29 x 10.3 x 5.37 x 4.05 x 5.76 x 5.09 x 4.55 x
EV / EBITDA 18 x 26.1 x 33.4 x 16.8 x 13.6 x 20.7 x 17.9 x 15.4 x
EV / FCF 146 x 287 x -449 x -39.2 x -91.6 x -238 x 1,026 x 133 x
FCF Yield 0.69% 0.35% -0.22% -2.55% -1.09% -0.42% 0.1% 0.75%
Price to Book 4.03 x 6.2 x 5.82 x 3.18 x 2.76 x 3.71 x 3.49 x 3.21 x
Nbr of stocks (in thousands) 74,246 74,289 74,283 74,189 74,282 72,117 - -
Reference price 2 353.2 568.8 761.6 453.1 353.7 495.2 495.2 495.2
Announcement Date 1/21/20 1/27/21 1/26/22 1/25/23 1/26/24 - - -
1CHF in Million2CHF
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 5,920 6,185 5,409 6,223 6,717 6,660 7,675 8,577
EBITDA 1 1,624 1,728 1,665 1,995 1,999 1,854 2,176 2,527
EBIT 1 1,249 1,358 1,151 1,397 939 1,157 1,480 1,807
Operating Margin 21.1% 21.96% 21.28% 22.45% 13.98% 17.37% 19.28% 21.06%
Earnings before Tax (EBT) 1 849 986 760 1,448 790 1,092 1,371 1,691
Net income 1 645 869 2,944 1,215 654 894 1,109 1,349
Net margin 10.9% 14.05% 54.43% 19.52% 9.74% 13.42% 14.45% 15.73%
EPS 2 8.650 11.63 39.52 16.34 8.880 12.25 15.36 18.59
Free Cash Flow 1 200 157 -124 -852 -297 -161.1 38.04 292.5
FCF margin 3.38% 2.54% -2.29% -13.69% -4.42% -2.42% 0.5% 3.41%
FCF Conversion (EBITDA) 12.32% 9.09% - - - - 1.75% 11.58%
FCF Conversion (Net income) 31.01% 18.07% - - - - 3.43% 21.68%
Dividend per Share 2 2.750 3.000 3.000 3.000 4.000 4.519 5.275 6.040
Announcement Date 1/21/20 1/27/21 1/26/22 1/25/23 1/26/24 - - -
1CHF in Million2CHF
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales 1 2,944 3,074 3,111 2,542 2,867 2,982 3,241 3,078 3,639 3,076 3,568
EBITDA 1 796 893 835 847 818 987 1,008 922 1,077 817.3 1,010
EBIT 1 606 706 652 606 545 698 699 563 376 527.2 644.4
Operating Margin 20.58% 22.97% 20.96% 23.84% 19.01% 23.41% 21.57% 18.29% 10.33% 17.14% 18.06%
Earnings before Tax (EBT) 1 407 564 422 296 464 594 854 486 304 470.2 602.4
Net income 1 346 477 392 319 2,625 492 723 410 244 389.3 495.9
Net margin 11.75% 15.52% 12.6% 12.55% 91.56% 16.5% 22.31% 13.32% 6.71% 12.65% 13.9%
EPS 2 4.640 6.390 5.240 4.280 35.24 6.610 9.730 5.540 3.340 5.310 6.780
Dividend per Share 2 - - 3.000 3.000 - - 3.000 3.500 - 4.000 -
Announcement Date 1/21/20 7/24/20 1/27/21 7/23/21 1/26/22 7/22/22 1/25/23 7/21/23 1/26/24 - -
1CHF in Million2CHF
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,961 2,813 - - 922 2,633 3,319 3,281
Net Cash position 1 - - 958 186 - - - -
Leverage (Debt/EBITDA) 1.823 x 1.628 x - - 0.4612 x 1.42 x 1.526 x 1.298 x
Free Cash Flow 1 200 157 -124 -852 -297 -161 38 293
ROE (net income / shareholders' equity) 10.1% 13.1% 35.5% 11.9% 6.52% 9.04% 11% 12.6%
ROA (Net income/ Total Assets) 4.65% 6.15% 19.1% 7.19% 3.82% 5.22% 6.25% 7.34%
Assets 1 13,884 14,135 15,444 16,907 17,103 17,127 17,749 18,394
Book Value Per Share 2 87.60 91.70 131.0 143.0 128.0 134.0 142.0 154.0
Cash Flow per Share 2 13.20 15.10 16.30 13.70 18.80 22.20 24.30 29.50
Capex 1 786 973 1,300 1,872 1,682 1,615 1,608 1,608
Capex / Sales 13.28% 15.73% 24.03% 30.08% 25.04% 24.26% 20.95% 18.74%
Announcement Date 1/21/20 1/27/21 1/26/22 1/25/23 1/26/24 - - -
1CHF in Million2CHF
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
495.2 CHF
Average target price
576.9 CHF
Spread / Average Target
+16.49%
Consensus
  1. Stock Market
  2. Equities
  3. LONN Stock
  4. Financials Lonza Group AG